133 related articles for article (PubMed ID: 28350158)
1. Oral Nanomedicine Based on Multicomponent Microemulsions for Drug-Resistant Breast Cancer Treatment.
Qu D; Wang L; Liu M; Shen S; Li T; Liu Y; Huang M; Liu C; Chen Y; Mo R
Biomacromolecules; 2017 Apr; 18(4):1268-1280. PubMed ID: 28350158
[TBL] [Abstract][Full Text] [Related]
2. Bitargeted microemulsions based on coix seed ingredients for enhanced hepatic tumor delivery and synergistic therapy.
Qu D; Sun W; Liu M; Liu Y; Zhou J; Chen Y
Int J Pharm; 2016 Apr; 503(1-2):90-101. PubMed ID: 26947738
[TBL] [Abstract][Full Text] [Related]
3. Transferrin-Functionalized Microemulsions Coloaded with Coix Seed Oil and Tripterine Deeply Penetrate To Improve Cervical Cancer Therapy.
Guo M; Qu D; Qin Y; Chen Y; Liu Y; Huang M; Chen Y
Mol Pharm; 2019 Dec; 16(12):4826-4835. PubMed ID: 31663764
[TBL] [Abstract][Full Text] [Related]
4. Octanoyl galactose ester-modified microemulsion system self-assembled by coix seed components to enhance tumor targeting and hepatoma therapy.
Qu D; Liu M; Huang M; Wang L; Chen Y; Liu C; Liu Y
Int J Nanomedicine; 2017; 12():2045-2059. PubMed ID: 28352174
[TBL] [Abstract][Full Text] [Related]
5. Microemulsion-based synergistic dual-drug codelivery system for enhanced apoptosis of tumor cells.
Qu D; Ma Y; Sun W; Chen Y; Zhou J; Liu C; Huang M
Int J Nanomedicine; 2015; 10():1173-87. PubMed ID: 25709440
[TBL] [Abstract][Full Text] [Related]
6. A multicomponent microemulsion using rational combination strategy improves lung cancer treatment through synergistic effects and deep tumor penetration.
Qu D; Guo M; Qin Y; Wang L; Zong B; Chen Y; Chen Y
Drug Deliv; 2017 Nov; 24(1):1179-1190. PubMed ID: 28841044
[TBL] [Abstract][Full Text] [Related]
7. Formulation, Preparation and Evaluation of Nanostructured Lipid Carrier Containing Naringin and Coix Seed Oil for Anti-Tumor Application Based on "Unification of Medicines and Excipients".
Zhu J; Huang Y; Zhang J; Feng Y; Shen L
Drug Des Devel Ther; 2020; 14():1481-1491. PubMed ID: 32368009
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of self-microemulsions for improved bioavailability of ginsenoside-Rh1 and Rh2.
Yang F; Zhou J; Hu X; Yu SK; Liu C; Pan R; Chang Q; Liu X; Liao Y
Drug Deliv Transl Res; 2017 Oct; 7(5):731-737. PubMed ID: 28677033
[TBL] [Abstract][Full Text] [Related]
9. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer.
Bu H; He X; Zhang Z; Yin Q; Yu H; Li Y
Int J Pharm; 2014 Aug; 471(1-2):206-13. PubMed ID: 24866272
[TBL] [Abstract][Full Text] [Related]
10. A Tf-modified tripterine-loaded coix seed oil microemulsion enhances anti-cervical cancer treatment.
Chen Y; Qu D; Fu R; Guo M; Qin Y; Guo J; Chen Y
Int J Nanomedicine; 2018; 13():7275-7287. PubMed ID: 30510417
[TBL] [Abstract][Full Text] [Related]
11. Triterpene-loaded microemulsion using Coix lacryma-jobi seed extract as oil phase for enhanced antitumor efficacy: preparation and in vivo evaluation.
Qu D; He J; Liu C; Zhou J; Chen Y
Int J Nanomedicine; 2014; 9():109-19. PubMed ID: 24379669
[TBL] [Abstract][Full Text] [Related]
12. Ganoderma lucidum-derived polysaccharide enhances coix oil-based microemulsion on stability and lung cancer-targeted therapy.
Guo J; Yuan C; Huang M; Liu Y; Chen Y; Liu C; Chen Y
Drug Deliv; 2018 Nov; 25(1):1802-1810. PubMed ID: 30343605
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor activity and attenuated cardiotoxicity of Epirubicin combined with Paeonol against breast cancer.
Wu J; Xue X; Zhang B; Cao H; Kong F; Jiang W; Li J; Sun D; Guo R
Tumour Biol; 2016 Sep; 37(9):12301-12313. PubMed ID: 27272157
[TBL] [Abstract][Full Text] [Related]
15. A novel injectable phospholipid gel co-loaded with doxorubicin and bromotetrandrine for resistant breast cancer treatment by intratumoral injection.
Luo JW; Zhang T; Zhang Q; Cao X; Zeng X; Fu Y; Zhang ZR; Gong T
Colloids Surf B Biointerfaces; 2016 Apr; 140():538-547. PubMed ID: 26628333
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer.
Li J; Yao QY; Xue JS; Wang LJ; Yuan Y; Tian XY; Su H; Wang SY; Chen WJ; Lu W; Zhou TY
Acta Pharmacol Sin; 2017 Sep; 38(9):1282-1296. PubMed ID: 28649130
[TBL] [Abstract][Full Text] [Related]
17. Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy.
Musende AG; Eberding A; Wood C; Adomat H; Fazli L; Hurtado-Coll A; Jia W; Bally MB; Guns ET
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1085-95. PubMed ID: 19301006
[TBL] [Abstract][Full Text] [Related]
18. Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration.
Dian LH; Hu YJ; Lin JY; Zhang JY; Yan Y; Cui YN; Su ZB; Lu WL
Int J Nanomedicine; 2018; 13():719-731. PubMed ID: 29440897
[TBL] [Abstract][Full Text] [Related]
19. Self-emulsifying System Co-loaded with Paclitaxel and Coix Seed Oil Deeply Penetrated to Enhance Efficacy in Cervical Cancer.
Chen Y; Wang S; Hu Q; Zhou L
Curr Drug Deliv; 2023; 20(7):919-926. PubMed ID: 35762559
[TBL] [Abstract][Full Text] [Related]
20. Novel oral administrated paclitaxel micelles with enhanced bioavailability and antitumor efficacy for resistant breast cancer.
Zhang T; Luo J; Fu Y; Li H; Ding R; Gong T; Zhang Z
Colloids Surf B Biointerfaces; 2017 Feb; 150():89-97. PubMed ID: 27898360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
